Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Judge

Showing results (41-50 of 260) with videos related to

Pageof 26
Sort By:
Journal of Cardiovascular Translational Research|March 7, 2015
Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosisThibaud Damy, Daniel P Judge, Arnt V Kristen, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|July 7, 2020
Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causesCortney Gensemer, Randall Burks, Steven Kautz, et al.
Journal of Cardiovascular Translational Research|January 27, 2022
Wild-Type Transthyretin Cardiac Amyloidosis Is Associated with Increased Antecedent Physical ActivityYi Zhen Joan Lee, Johana Fajardo, Emily Brown, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 28, 2015
Fluctuating creatinine in the cardiac unitAthena K Petrides, Mary Ann Ness, Daniel P Judge, et al.
Nucleus (Austin, Tex.)|December 5, 2023
The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-BKamsi O Odinammadu, Khurts Shilagardi, Kelsey Tuminelli, et al.
Journal of Cardiovascular Translational Research|September 13, 2011
The mitral valve in hypertrophic cardiomyopathy: old versus new conceptsAlbert A Hagège, Patrick Bruneval, Robert A Levine, et al.
Journal of Genetic Counseling|September 21, 2023
Applying the R = MC<sup>2</sup> implementation science heuristic to assess the impact of readiness on reach and implementation of a population-wide genomic screening programCaitlin G Allen, Kelly J Hunt, Amy Jackson, et al.
The New England Journal of Medicine|June 27, 2008
Angiotensin II blockade and aortic-root dilation in Marfan's syndromeBenjamin S Brooke, Jennifer P Habashi, Daniel P Judge, et al.
Pediatric Cardiology|January 5, 2008
Familial hypertrophic cardiomyopathy associated with cardiac beta-myosin heavy chain and troponin I mutationsAisha Frazier, Daniel P Judge, Steven P Schulman, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 1, 2018
Seven factors predict a delayed diagnosis of cardiac amyloidosisEve Bishop, Emily E Brown, Johana Fajardo, et al.
Pageof 26

Showing results (41-50 of 260) with videos related to

Sort By:
Pageof 26
Journal of Cardiovascular Translational Research|March 7, 2015
Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosisThibaud Damy, Daniel P Judge, Arnt V Kristen, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|July 7, 2020
Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causesCortney Gensemer, Randall Burks, Steven Kautz, et al.
Journal of Cardiovascular Translational Research|January 27, 2022
Wild-Type Transthyretin Cardiac Amyloidosis Is Associated with Increased Antecedent Physical ActivityYi Zhen Joan Lee, Johana Fajardo, Emily Brown, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 28, 2015
Fluctuating creatinine in the cardiac unitAthena K Petrides, Mary Ann Ness, Daniel P Judge, et al.
Nucleus (Austin, Tex.)|December 5, 2023
The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-BKamsi O Odinammadu, Khurts Shilagardi, Kelsey Tuminelli, et al.
Journal of Cardiovascular Translational Research|September 13, 2011
The mitral valve in hypertrophic cardiomyopathy: old versus new conceptsAlbert A Hagège, Patrick Bruneval, Robert A Levine, et al.
Journal of Genetic Counseling|September 21, 2023
Applying the R = MC<sup>2</sup> implementation science heuristic to assess the impact of readiness on reach and implementation of a population-wide genomic screening programCaitlin G Allen, Kelly J Hunt, Amy Jackson, et al.
The New England Journal of Medicine|June 27, 2008
Angiotensin II blockade and aortic-root dilation in Marfan's syndromeBenjamin S Brooke, Jennifer P Habashi, Daniel P Judge, et al.
Pediatric Cardiology|January 5, 2008
Familial hypertrophic cardiomyopathy associated with cardiac beta-myosin heavy chain and troponin I mutationsAisha Frazier, Daniel P Judge, Steven P Schulman, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 1, 2018
Seven factors predict a delayed diagnosis of cardiac amyloidosisEve Bishop, Emily E Brown, Johana Fajardo, et al.
Pageof 26